A three-part controlled study of trimebutine in the treatment of irritable colon syndrome

Current Medical Research and Opinion
K Lüttecke


Three controlled trials were carried out in patients with irritable bowel syndrome to assess the effectiveness of trimebutine in controlling the symptoms of abdominal distension, pain, flatulence, constipation, diarrhoea and dyspepsia. In the first two trials, it was shown that 200 mg trimebutine 3-times daily for 3 days produced rapid relief of symptoms and was significantly (p less than 0.001) more effective than placebo, but not significantly so when the dosage level was halved. In the third trial, the results showed that 200 mg trimebutine 3-times daily for 2 weeks was as effective as 100 mg mebeverine 4-times daily in relieving the major symptoms and in improving motility. No serious side-effects were reported with trimebutine at the dosage used.


Jan 1, 1978·The Journal of International Medical Research·K Lüttecke
Jan 1, 1979·The Journal of International Medical Research·M G Moshal, M Herron


Dec 15, 1987·European Journal of Pharmacology·H KotakeH Mashiba
Apr 3, 1991·European Journal of Pharmacology·M NagasakiH Tamaki
May 3, 2005·Gastroenterology Clinics of North America·Philip Schoenfeld
Feb 24, 2001·Alimentary Pharmacology & Therapeutics·T PoynardY Benhamou
Sep 1, 1993·British Journal of Pharmacology·M NagasakiH Ohashi
May 10, 2007·Gut·R SpillerClinical Services Committee of The British Society of Gastroenterology
Feb 4, 2010·World Journal of Gastroenterology : WJG·Mahnaz Darvish-DamavandiMohammad Abdollahi
Nov 8, 2013·Journal of Neurogastroenterology and Motility·A Young SeoDong Hyun Oh
May 1, 1996·Scandinavian Journal of Gastroenterology·P S EfskindM H Vatn
Apr 15, 2011·Alimentary Pharmacology & Therapeutics·M Schmulson, L Chang
May 1, 1989·The Journal of Pharmacy and Pharmacology·O IgawaH Mashiba
Jun 8, 2012·Revista de gastroenterología de México·M A Martínez-VázquezF J Bosques-Padilla
Nov 25, 2011·Allergology International : Official Journal of the Japanese Society of Allergology·Suh-Young LeeHye-Ryun Kang
Jun 5, 2016·Gastroenterology Clinics of North America·Lucinda A HarrisMargaret M Heitkemper
Feb 26, 2011·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Joong Goo KwonKorean Society of Neurogastroenterology and Motility
Jul 18, 2006·Alimentary Pharmacology & Therapeutics·J TackG Fisher
Aug 13, 2011·The Cochrane Database of Systematic Reviews·Lisa RuepertJean Wm Muris
Oct 1, 1994·Alimentary Pharmacology & Therapeutics·T PoynardJ C Chaput
May 1, 1987·The Journal of Pharmacy and Pharmacology·F RomanJ L Junien
Nov 19, 1997·The Journal of International Medical Research·M Delvaux, D Wingate
Oct 17, 2019·Minerva gastroenterologica e dietologica·Beatrice Salvioli
Feb 5, 2021·Journal of Gastroenterology·Shin FukudoKazuhiko Koike

Related Concepts

Mebeverine hydrochloride
Clinical Trials
Colonic Diseases, Functional
Double-Blind Method

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.